KalGene Pharmaceuticals

0 followers

‌

Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.

Industries

Headquarters

Employees

Links

Org chart

Nickolay V. Kukekov

President & CEO

Nickolay V. Kukekov

Collapse

Jeff Irwin

CFO

Albert Agro

Acting Chief Medical Officer

Guriq S. Basi

Head of Preclinical Studies

Teams

Leadership Team

0 members

Similar companies

Azelis

2 followers

GSK

233 followers

AstraZeneca

213 followers

Novo Nordisk

219 followers

Bristol-Myers Squibb

163 followers

Takeda Pharmaceutical

101 followers

Alnylam Pharmaceuticals

18 followers

ICON

17 followers

Syneos Health

16 followers

Ferring Pharmaceuticals

13 followers

Karyopharm Therapeutics

12 followers

Discover companies